Sun Pharma gets labeling supplement approved for carbidopa and levodopa tablets
A labeling change for Sun Pharmaceutical Industries' generic carbidopa and levodopa tablets was approved on September 11, 2026.
Sun Pharmaceutical Industries had a labeling supplement approved for its carbidopa and levodopa tablets, according to FDA drug application records.
- Sun Pharmaceutical Industries' carbidopa and levodopa tablets, sold under application number ANDA078536, had a labeling supplement (submission number 28) approved, with the submission status listed as approved on a status date of September 11, 2026.1 The product is available in three combination strengths of carbidopa and levodopa in tablet form for oral use.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.